Arthritis drug used to treat coronavirus patients in China helped to cure 95 per cent of critically ill, scientists say
See more at the link https://www.thesun.co.uk/news/112566...rus-cure-hope/
Excerpt:
The drug - manufactured by Swiss giant Roche - works by reducing levels of certain proteins in the body which people with rheumatoid arthritis have too much of.
Medics in China trialed tocilizumab to combat an overreaction of the immune system witnessed in some of those struck down with the killer virus.
The shocking condition is seen as a major factor behind catastrophic organ failure which has lead to death in some patients.
Doctors in the outbreak centre of China first used the drug last month on those with "severe and critical' symptoms" and they say the results were astounding.
Within a few days, patients' fever returned to normal and all other symptoms improved remarkably, Dr Xiaoling Xu and colleagues report.
Fifteen of the 20 trial patients were able to have their oxygen intake lowered within days and 19 patients were eventually discharged.The other patient is recovering well, the study claims.
CT scans also showed damage to the lungs reduced significantly around the fourth and fifth day of treatment.
The report authors conclude: 'Tocilizumab is an effective treatment in severe patients of COVID-19, which provided a new therapeutic strategy for this fatal infectious disease.'
Roche, which donated £1.5m worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients.